By indication / Thyroid cancer
Thyroid cancer
8 imaging agents and 7 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [68Ga]Ga-FAPI paired with [177Lu]Lu-FAPI | Ga-68 | Clinical research | 5 |
| [68Ga]Ga-DOTA-CCK-66 paired with [177Lu]Lu-DOTA-CCK-66 | Ga-68 | Clinical research | 2 |
| [68Ga]Ga-FAPI-74 | Ga-68 | — | 1 |
| [99mTc]N4-CCK-100 | Tc-99m | Preclinical | 1 |
| [68Ga]DOTA-MGS8 | Ga-68 | Preclinical | 1 |
| [18F]NaBF4 | F-18 | Reported once | 1 |
| [99mTc]HYNIC-MGS5 | Tc-99m | Reported once | 1 |
| [99mTc]HYNIC-MGS11 | Tc-99m | Reported once | 1 |
Therapy
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [177Lu]Lu-DOTA-MGS5 | Lu-177 | Clinical research | 8 |
| [177Lu]Lu-PP-F11N | Lu-177 | Clinical research | 3 |
| [177Lu]Lu-DOTA-PP-F11N | Lu-177 | Clinical research | 2 |
| [177Lu]Lu-DOTA-CCK-66 paired with [68Ga]Ga-DOTA-CCK-66 | Lu-177 | Preclinical | 2 |
| [225Ac]Ac-DOTA-CCK-66 paired with [68Ga]Ga-DOTA-CCK-66 | Ac-225 | Preclinical | 1 |
| [211At]At-NaAt | At-211 | Clinical research | 1 |
| [90Y]Y-DOTA-DPhe1-Tyr3-octreotide | Y-90 | — |
Other entries
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [111In]In-minigastrin | In-111 | — | 2 |
| [177Lu]Lu-DOTA-cyclo-MG1 | Lu-177 | Preclinical | 1 |
| [177Lu]Lu-DOTA-cyclo-MG2 | Lu-177 | Preclinical | 1 |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.
Get in touch